SHARE-BASED COMPENSATION (Details) (USD $)	3 Months Ended	12 Months Ended				12 Months Ended							0 Months Ended		12 Months Ended			0 Months Ended			12 Months Ended
	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013 2011 Omnibus Incentive Plan	Dec. 31, 2011 Cost of goods sold	Dec. 31, 2012 Research and development expenses	Dec. 31, 2011 Research and development expenses	Dec. 31, 2013 Selling, general and administrative expenses	Dec. 31, 2012 Selling, general and administrative expenses	Dec. 31, 2011 Selling, general and administrative expenses	Dec. 31, 2011 Restructuring and other costs	Mar. 08, 2011 Stock options	Nov. 04, 2010 Stock options	Dec. 31, 2013 Stock options	Dec. 31, 2012 Stock options	Dec. 31, 2011 Stock options	Mar. 08, 2011 Stock options Cost of goods sold	Mar. 08, 2011 Stock options Research and development expenses	Mar. 08, 2011 Stock options Selling, general and administrative expenses	Dec. 31, 2013 RSUs	Dec. 31, 2012 RSUs	Dec. 31, 2011 RSUs	Dec. 31, 2013 RSUs Selling, general and administrative expenses	Dec. 31, 2012 RSUs Selling, general and administrative expenses
Components and classification of share-based compensation expense
Total number of shares approved for grant by the Company under the share-based compensation plans					6,846,310
Number of shares available for future grants					160,817
Stock-based compensation expense		$ 45,478,000	$ 66,236,000	$ 94,023,000		$ 1,330,000	$ 764,000	$ 1,329,000	$ 45,478,000	$ 65,472,000	$ 90,379,000	$ 985,000			$ 17,317,000	$ 21,739,000	$ 45,465,000				$ 28,161,000	$ 44,497,000	$ 48,558,000	$ 4,300,000	$ 4,800,000
Post-merger special dividend (in dollars per share)														$ 1.00
Incremental fair value of the modified awards													15,400,000
Incremental fair value of the modified awards for options vested													9,200,000					200,000	200,000	8,800,000
Incremental fair value of the modified awards for unvested options													6,200,000
Reduction in stock-based compensation expense due to change in classification from equity awards to liability awards	5,800,000
Stock-based compensation expense due to change in classification from equity awards to liability awards	21,300,000
Tax benefits from stock options exercised		$ (24,200,000)	$ (12,541,000)	$ (26,533,000)